Clario appoints Julia James as Chief Legal and Administrative Officer

Legal and compliance expert Julia James, previously with Thermo Fisher Scientific, joins Clario to drive legal and compliance strategy

PHILADELPHIA, PA – April 8, 2024 – Clario, a healthcare research and technology company that delivers the leading endpoint technology solutions for clinical trials, today announced the appointment of Julia James as the company’s Chief Legal and Administrative Officer. This appointment bolsters Clario’s strategic focus on improving the customer experience and differentiating its offerings.

“We are excited to welcome Julia James to Clario,” said Chris Fikry, M.D., Chief Executive Officer at Clario. “Her extensive legal and compliance expertise will help us continue to advance Clario’s impact in clinical trials, further enhancing our efforts on quality and speed to empower our partners to transform lives.”

Julia served as Executive Vice President and General Counsel of PPD, the leading contract research organization, until its acquisition by Thermo Fisher Scientific in 2021. She then continued as General Counsel, Clinical Research, following the transaction. Julia spent more than 15 years in various legal leadership roles at PPD and, prior to that, worked for the international law firm Clifford Chance in both London and Dubai. She is passionate about empowering women in business to succeed individually and collectively.

“Clario plays a pivotal role in the clinical trial ecosystem through the generation of the highest quality evidence and developing transformative technologies,” she said. “It is a privilege to have the opportunity to join such a high-performing team focused on improving the health of patients around the world.”

For more information, go to Clario.com and follow us on LinkedIn.